Back to News
Market Impact: 0.15
Buy Moderna Stock Before Q3 Earnings? Here's What to Know
Source: zacks.com
Corporate EarningsAnalyst EstimatesHealthcare & Biotech
Moderna is scheduled to report third-quarter 2026 earnings on Nov. 6 before the opening bell. The Zacks Consensus Estimate is $888.8 million in sales and a loss of $1.37 per share; the article reports estimates, not actual results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.05
More News
- Palantir reports booming U.S. commercial revenue growth, topping government for first time
- Anthropic releases amended IPO prospectus with third-quarter financials
- Coinbase has been battered over the past month. Morgan Stanley says steer clear
- Anthropic to Spend $895 Billion in the Years Ahead
- New Apple CEO John Ternus chalks up some early wins, but the honeymoon is over
- Reliance’s Record $19 Billion Surge Lifts Nifty, Keeps India Bulls in the Game